Zopiclone
SIGMA/Z4900
Synonym: 4-
CAS Number: 43200-80-2
Empirical Formula (Hill Notation): C17H17ClN6O3
Molecular Weight: 388.81
EC Number: 256-138-9
MDL Number: MFCD00133931
Linear Formula: C17H17ClN6O3
Product Type: Chemical
| drug control | USDEA Schedule IV; psychotrope (France); regulated under CDSA - not available from Sigma-Aldrich Canada |
| InChI | 1S/C17H17ClN6O3/c1-22-6-8 |
| InChI key | GBBSUAFBMRNDJC-UHFFFAOYSA |
| originator | Dainippon Sumitomo |
| Quality Level | 200 ![]() |
| SMILES string | CN1CCN(CC1)C(=O)OC2N(C(=O |
| solubility | DMSO: 2 mg/mL |
| H2O: insoluble |
| Biochem/physiol Actions: | Benzodiazepine receptor agonist |
| Features and Benefits: | This compound is a featured product for Neuroscience research. Click here to discover more featured Neuroscience products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
| Features and Benefits: | This compound is featured on the GABAA Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Features and Benefits: | This compound was developed by Dainippon Sumitomo . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 - H336 |
| Precautionary statements | P301 + P312 + P330 |
| Hazard Codes | Xn |
| Risk Statements | 20/21/22-36/37/38-62 |
| Safety Statements | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 12352200 |


